CN105224841A - The quantitative detection management method and system of a kind of network intelligence fluorescence immunoassay - Google Patents
The quantitative detection management method and system of a kind of network intelligence fluorescence immunoassay Download PDFInfo
- Publication number
- CN105224841A CN105224841A CN201410242622.5A CN201410242622A CN105224841A CN 105224841 A CN105224841 A CN 105224841A CN 201410242622 A CN201410242622 A CN 201410242622A CN 105224841 A CN105224841 A CN 105224841A
- Authority
- CN
- China
- Prior art keywords
- user
- account
- finger print
- print data
- far
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 46
- 238000007726 management method Methods 0.000 title claims abstract description 43
- 238000003018 immunoassay Methods 0.000 title claims abstract description 42
- 238000007405 data analysis Methods 0.000 claims abstract description 6
- 238000012360 testing method Methods 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 7
- 230000002159 abnormal effect Effects 0.000 claims description 5
- 238000005259 measurement Methods 0.000 abstract description 2
- 238000010200 validation analysis Methods 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 6
- 238000004171 remote diagnosis Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004891 communication Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- -1 urine Substances 0.000 description 1
Landscapes
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The present invention is applicable to technical field of medical instruments, provides a kind of network intelligence fluorescence immunoassay quantitative detection management method and system.Described system comprises fluorescence immunoassay instrument and far-end server, both wireless networks connect, healthy and the remote assistant diagnostic system of described invention system fluorescence immunoassay instrument and network digital, be incorporated into an Intelligent Measurement platform, the present invention achieves wireless network access on existing fluorescence immunoassay instrument basis, and construct fingerprint identity validation, account is set up and access schemes, according to finger print data for user sets up account, the history of preserving user in remote server detects data, remote server is to detection data analysis, provide diagnostic result.The present invention can be widely used in basic hospital, community service, domestic consumer, extensive patients can be stayed indoors and enjoy high-caliber consulting services.
Description
Technical field
The invention belongs to technical field of medical instruments, particularly relate to the quantitative detection management method and system of a kind of network intelligence fluorescence immunoassay.
Background technology
Current Internet technology develops rapidly, and rapid permeability is to each traditional industries: education, retail, finance, medium etc., and brings revolutionary impact to these traditional industries.Present people can stay indoors and do shopping, and sheet of seeing a film listens high-level lecture, have only to see a doctor health check-up and must go out, and look for expert to realize to large hospital.Some chronic diseases or the high paroxysmal disease of mortality ratio, as the disease such as myocardial infarction, headstroke, can to detect fast at home and doctor to large hospital transmits testing result immediately? the present invention is exactly that Internet technology is applied in the one of medical detection industry.
Fluorescence immunity analyzer is widely used in fields such as disease quick diagnosis, Small molecular detections.Its principle is that have two species specific antibody above, a kind of antibody labeling has fluorescent material, and another kind of antibody is fixed on the detection line in test card by its matching used various test card.When the sample (blood or urine) of user is added in test card, sample can the nitrocellulose filter in test card spread, if containing the differential protein that will measure, it is by elder generation and be marked with the reaction of fluorescent material generation antibody antigen, be split into antibody--antigenic compound, this compound can continue to diffuse to detection line under the pulling of liquid diffusive force, and the second antibody combines again, form antibody--compound of antigen--antibody--fluorescein, and be fixed on detection line.Other albumen and unnecessary fluorescence antibody can leave detection line under the pulling of liquid diffusive force, are diffused into adsorptive pads.After diffusion terminates, fluorescence immunity analyzer inspires fluorescence by external light source on Test paper, is separated and reads the intensity of exciting light, and often criticizing the correction parameter of test card, calculating the content of tested substance.This is Fast Detection Technique newer at present, and shortcoming needs professional to operate, and needs to detect to hospital, and the result of detection wants knot medical practitioners to carry out analyzing and passing judgment on.
Remote diagnosis Technology application computing machine, communication, medical skill and equipment, by the Long Distant Transmit of data, word, voice and image document, realize expert and patient, the consultation of doctors in strange land " face-to-face " between expert and medical worker.Tele-medicine is not only medical treatment or clinical problem, also comprises communication network, database each side problem, and needs them to be integrated in network system.The method of service of Telemedicine System is divided into again (online) mode and non real-time (off-line) mode two kinds in real time.Real-time mode uses when referring to conditions permit or emergency condition, patient can be made to obtain and succour timely, but cost is higher, and operation easier is larger; Non-real time refers to and sends the data of demand for medical service side to service provider at any time, waits pending.The data that the expert being positioned at large hospital can provide according to user makes corresponding diagnosis.Remote diagnosis needs Data support, as the detection technique of the physiology such as cardiogram, blood pressure, blood oxygen and electric-physiology parameter, and the medical imaging technology such as B ultrasonic, CT, the detection technique of the various biochemical content's index of blood, urine, body fluid.Feature due to tele-medicine be patient in distant, the information that can obtain when some is medical face-to-face possibly cannot obtain or cannot directly obtain.These problems significantly limit the application of tele-medicine.
Summary of the invention
In view of the above problems, the object of the present invention is to provide the quantitative detection management method and system of a kind of network intelligence fluorescence immunoassay, being intended to solve existing fluorescence immunoassay instrument can only carry out Data Detection, cannot realize the technical matters of remote diagnosis.
On the one hand, in fluorescence immunoassay instrument side, the quantitative detection management of described network intelligence fluorescence immunoassay comprises the steps:
Obtain user fingerprints data;
When receiving domestic consumer's instruction, judge whether there is described finger print data in local regular account;
If there is described finger print data, then preserve current detection result and be saved in fixing account corresponding to described finger print data, described testing result being uploaded to far-end server simultaneously;
If there is not described finger print data, then set up holding account and described finger print data and testing result are uploaded to far-end server; Upgrade user profile to make far-end server and return user ID;
When after the user ID receiving far-end server passback, if this locality exists fixing account corresponding to described user ID, then to download and the history of preserving this user detects data, otherwise upgrade described holding account for fixing account according to described user ID.
On the other hand, in far-end server side, the quantitative detection management method of described network intelligence fluorescence immunoassay, comprising:
The testing result that reception detector is uploaded and finger print data;
Judge whether to there is the user account corresponding with described finger print data;
Directly preserve testing result when it is present, and return user ID corresponding to described user account to detector;
When not existing, distributing a user ID for described finger print data and setting up user account, returning described user ID to detector simultaneously.
The third aspect, described fluorescence immunoassay instrument comprises:
Fingerprint acquiring unit, for obtaining user fingerprints data;
Fingerprint judging unit, for when receiving domestic consumer's instruction, judges whether there is described finger print data in local regular account;
Data preserve uploading unit, if for there is described finger print data, then preserve current detection result and are saved in fixing account corresponding to described finger print data, described testing result being uploaded to far-end server simultaneously;
Account sets up unit, if for there is not described finger print data, then sets up holding account and described finger print data and testing result are uploaded to far-end server; Upgrade user profile to make far-end server and return user ID;
Account update process unit, for when receive far-end server passback user ID after, if this locality exists fixing account corresponding to described user ID, then to download and the history of preserving this user detects data, otherwise upgrade described holding account for fixing account according to described user ID.
Fourth aspect, described far-end server comprises:
Data receipt unit, for receiving the testing result and finger print data that detector uploads;
, there is the user account corresponding with described finger print data for judging whether in account judging unit;
User ID back propagation unit, for directly preserving testing result when it is present, and returns user ID corresponding to described user account to detector;
Account sets up unit, for when not existing, distributing a user ID and set up user account for described finger print data, returns described user ID to detector simultaneously.
5th aspect, described network intelligence fluorescence immunoassay quantitative detection management system comprises above-mentioned fluorescence immunoassay instrument and far-end server, and both are connected by wireless network.
The invention has the beneficial effects as follows: existing fluorescence immunoassay instrument needs professional to operate, and detects to hospital, the result of detection wants knot medical practitioners to carry out analyzing and passing judgment on; In distant, the information that can obtain when some is gone to a doctor face-to-face possibly cannot obtain or cannot directly obtain tele-medicine patient, and this significantly limit the application of tele-medicine; The present invention achieves wireless network access on existing fluorescence immunoassay instrument basis, and construct fingerprint identity validation, account is set up and access schemes, according to finger print data for user sets up account, the history of preserving user in remote server detects data, remote server, to detection data analysis, provides diagnostic result.The present invention can be widely used in basic hospital, community service, domestic consumer, extensive patients can be stayed indoors and enjoy high-caliber consulting services.
Accompanying drawing explanation
Fig. 1 is the process flow diagram of the quantitative detection management method of network intelligence fluorescence immunoassay that first embodiment of the invention provides;
Fig. 2 is the process flow diagram of the quantitative detection management method of network intelligence fluorescence immunoassay that second embodiment of the invention provides;
Fig. 3 is the block diagram of the fluorescence immunoassay instrument that third embodiment of the invention provides;
Fig. 4 is the block diagram of the far-end server that fourth embodiment of the invention provides;
Fig. 5 is the structural drawing of the quantitative detection management system of network intelligence fluorescence immunoassay that fifth embodiment of the invention provides.
Embodiment
In order to make object of the present invention, technical scheme and advantage clearly understand, below in conjunction with drawings and Examples, the present invention is further elaborated.Should be appreciated that specific embodiment described herein only in order to explain the present invention, be not intended to limit the present invention.
The present invention relates to a kind of rapid and handy formula fluorescence immunoassay instrument and with this detector be data terminal network digital health system and remote assistant diagnostic system.The present invention is by rapid and handy formula fluorescence immunoassay instrument and network digital is healthy and remote assistant diagnostic system, is incorporated into an Intelligent Measurement platform.Have powerful measuring ability compared with current simple remote diagnosis system, comparing the present invention with simple immune detector can be the analysis stored data of each patient's science, and provides remote assistant to diagnose according to the data of preserving.In order to technical solutions according to the invention are described, be described below by specific embodiment.
embodiment one:
Fig. 1 shows the quantitative detection management method of network intelligence fluorescence immunoassay that the embodiment of the present invention provides, and illustrate only the part relevant to the embodiment of the present invention for convenience of explanation.
The present embodiment describes the quantitative detection management method of network intelligence fluorescence immunoassay from fluorescence immunoassay instrument side, as shown in Figure 1, comprises the steps:
Step S101, acquisition user fingerprints data.
First need to arrange fingerprint sensor on fluorescence immunoassay instrument.Carry out health status detection by detector to user, according to different environment for use, described detecting device can detect and obtain all kinds of health data, does not repeat here.When testing result preserved by needs, user needs typing finger print data, concrete, obtains user fingerprints data by described fingerprint sensor.
Step S102, when receiving domestic consumer's instruction, judge whether there is described finger print data in local regular account.
As a kind of embodiment, after getting user fingerprints data, leading subscriber and domestic consumer two buttons can be demonstrated on a display screen, when user selects domestic consumer, detector receives domestic consumer's instruction, judges whether be divided into described finger print data in the local regular account of detector further.
If step S103 exists described finger print data, then preserve current detection result and be saved in fixing account corresponding to described finger print data, described testing result being uploaded to far-end server simultaneously, also can uploading finger print data simultaneously.
If there is described finger print data in regular account, then directly preserve in the described testing result fixing account that extremely described finger print data is corresponding, testing result is associated with corresponding fixing account, described result is uploaded to far-end server simultaneously, if there is corresponding fixing account same in far-end server, far-end server preserves described testing result.
If step S104 does not exist described finger print data, then set up holding account and described finger print data and testing result are uploaded to far-end server; Upgrade user profile to make far-end server and return user ID.
If there is not described finger print data in regular account, illustrate that active user is new user, then set up holding account, and described finger print data and testing result are uploaded to far-end server, far-end server judges whether this locality exists described finger print data, if exist, then preserve testing result and return corresponding user ID.If do not deposit, then set up new user account, and distribute a user ID for this user account, and preserve described testing result, then user ID is back to detector.Here user ID is uniquely corresponding with user account, finger print data.
Step S105, when after the user ID receiving far-end server passback, if this locality exists fixing account corresponding to described user ID, then to download and the history of preserving this user detects data, otherwise upgrade described holding account for fixing account according to described user ID.
After detector receives the user ID of far-end server passback, detect in this locality and whether preserve fixing account corresponding to described user ID, if cross existence, then download and preserve this user history detect data, if do not exist, described holding account is updated to the fixing account corresponding with described user ID.Such active user just becomes known users, when subsequent detection is fashionable to fingerprint brush, directly preserves testing result.
Be further used as one preferred embodiment, described method also comprises the steps:
Step S106, when receiving leading subscriber instruction, if there is described finger print data in local management account, then enter management mode, otherwise etc. the administrator password of user to be obtained input, if the administrator password obtained is correct, in account executive, preserves described finger print data and enter management mode.
When after user's typing fingerprint, display screen can demonstrate leading subscriber and domestic consumer two buttons, when user selects leading subscriber, detector generates management user instruction, now detects in local management account whether there is described finger print data, if exist, then enter management mode, otherwise need password authentification, only have when user inputs correct administrator password, just can enter management mode, in account executive, preserve described finger print data simultaneously.Next time directly can enter management mode by typing fingerprint.
In this optimal way, if user needs to carry out instrument management operation, then can run independent management application, in management application, fingerprint must be inputted to determine keeper's identity, if finger print information is not in account executive, then need input administrator's password to confirm identity.
Preferred further, described method also comprises the steps:
Preserve the diagnostic result information that far-end server passes down, when diagnostic result is for sending alarm signal time abnormal.
By logging in far-end server, healthcare givers can check that the history of each user detects data, the diagnostic result of user can be provided by these data, and reach detector by under far-end server, detector is preserved described diagnostic result and is associated with corresponding fixing account, sends alarm signal reminding user when diagnostic result has exception.This optimal way achieves remote diagnosis, extensive patients can be stayed indoors and enjoy high-caliber consulting services.
embodiment two:
Fig. 2 shows the quantitative detection management method of network intelligence fluorescence immunoassay that the embodiment of the present invention provides, and illustrate only the part relevant to the embodiment of the present invention for convenience of explanation.
The present embodiment distally server side describes the quantitative detection management method of network intelligence fluorescence immunoassay, as shown in Figure 2, comprises the steps:
The testing result that step S201, reception detector are uploaded and finger print data.
Far-end server end needs consistent with the user data of detector.Remote server can receive the testing result and finger print data that detector uploads.
Step S202, judge whether to there is the user account corresponding with described finger print data.
First need to judge in local account database, whether to there is user account corresponding to described finger print data, generally, each user account data comprise some essential informations (as name, sex, age etc.), user ID, user fingerprints data, history detect data, all previous complementary diagnostic information and other relevant informations.
Step S203, directly preserve testing result when it is present, and return user ID corresponding to described user account to detector.
If there is described finger print data in far-end server, then directly preserve described testing result, and return the user ID of respective user account.
Step S204, when not existing, distributing a user ID for described finger print data and setting up user account, returning described user ID to detector simultaneously.
If there is not described finger print data in far-end server, then create a user account for described job data, distribute a unique subscriber ID simultaneously, and return described user ID to detector.
Preferred further, the present embodiment method also comprises the steps:
The history corresponding to each user account detects data analysis, and to detector passback diagnostic result.
Far-end server detects data according to the history of each user account and carries out correlation analysis, obtains the diagnostic result of user, and returns described diagnostic result to detector.Described diagnostic result includes user ID.
embodiment three:
Fig. 3 shows the block diagram of the fluorescence immunoassay instrument that the embodiment of the present invention provides, and illustrate only the part relevant to the embodiment of the present invention for convenience of explanation.
The fluorescence immunoassay instrument that the present embodiment provides comprises:
Fingerprint acquiring unit 301, for obtaining user fingerprints data;
Fingerprint judging unit 302, for when receiving domestic consumer's instruction, judges whether there is described finger print data in local regular account;
Data preserve uploading unit 303, if for there is described finger print data, then preserve current detection result and are saved in fixing account corresponding to described finger print data, described testing result being uploaded to far-end server simultaneously;
Account sets up unit 304, if for there is not described finger print data, then sets up holding account and described finger print data and testing result are uploaded to far-end server; Upgrade user profile to make far-end server and return user ID;
Account update process unit 305, for when receive far-end server passback user ID after, if this locality exists fixing account corresponding to described user ID, then to download and the history of preserving this user detects data, otherwise upgrade described holding account for fixing account according to described user ID.
Each functional section unit 301-305 correspondence above-mentioned achieves the step S101-S105 in embodiment one, achieved by each functional unit above-mentioned and detector is combined with fingerprint authentication, by fingerprint recognition user identity, simultaneously also for user sets up remote account, preserve the testing result of each user.
Preferably, described detector also comprises:
Management control unit 306, for when receiving leading subscriber instruction, if there is described finger print data in local management account, then enter management mode, otherwise etc. the administrator password of user's input to be obtained, if the administrator password obtained is correct, in account executive, preserves described finger print data and enter management mode.
Preferred further, described detector also comprises:
Result treatment unit, for preserving the diagnostic result information that far-end server passes down, when diagnostic result is for sending alarm signal time abnormal.
The detector result that the present embodiment provides is simple, achieves and far-end server telecommunication, existing fluorescence immunoassay instrument basis achieves remote diagnosis.
embodiment four:
Fig. 4 shows the block diagram of the far-end server that the embodiment of the present invention provides, and illustrate only the part relevant to the embodiment of the present invention for convenience of explanation.
The far-end server that the present embodiment provides comprises:
Data receipt unit 401, for receiving the testing result and finger print data that detector uploads;
, there is the user account corresponding with described finger print data for judging whether in account judging unit 402;
User ID back propagation unit 403, for directly preserving testing result when it is present, and returns user ID corresponding to described user account to detector;
Account sets up unit 404, for when not existing, distributing a user ID and set up user account for described finger print data, returns described user ID to detector simultaneously.
Above-mentioned each functional unit 401-404 correspondence achieves the step S201-S204 in embodiment two, achieves the detection data to user and user account management.At far-end server, for new fingerprint, generate it and fix and unique user ID, and set up long-distance user's account for this user ID, for the finger print information stored, give the access rights of the user account of its association, testing result is saved in long-distance user's account simultaneously.
Preferred further, described far-end server also comprises:
Diagnostic analysis unit, detects data analysis for the history corresponding to each user account, and to detector passback diagnostic result.
Diagnostic analysis unit detects data to the history of each user and carries out instant trace analysis, and provides diagnostic result and treatment suggestion pushes to detector; To obviously abnormal testing result, intelligent expert system sends warning signal while providing auxiliary diagnosis result, and pushes to detector.
embodiment five:
Fig. 5 shows the structure of the quantitative detection management system of network intelligence fluorescence immunoassay that the embodiment of the present invention provides, and illustrate only the part relevant to the embodiment of the present invention for convenience of explanation.
The quantitative detection management system of the network intelligence fluorescence immunoassay that the present embodiment provides comprises the fluorescence immunoassay instrument as described in embodiment three and the remote server as described in embodiment four, and both are connected by wireless network.During specific implementation, wireless network (WIFI) process chip can be embedded in detecting instrument, enable detecting instrument by WIFI hot spot accessing Internet; Or embed mobile network (GPRS/3G/4G) process chip, enable detector by the data network accessing Internet of mobile operator, meanwhile, sim card slot is set in instrument, to insert the SIM card with mobile network feature.Be connected with far-end server by internet.Also need in addition in detector, to embed fingerprint sensor, by finger print information identification user identity, and by testing result and user identification relevancy.
Described detector part, adopt arm processor nest plate (the dull and stereotyped implementation of such as Android, use the manufacturer such as MTK or high pass chip) and Android operation system solution, build embedded computer system, realize data processing, WIFI and mobile Internet access function, integrated fingerprint sensor (notebook computer with or gate inhibition's type) realizes fingerprint identification function.Network insertion makes testing result be uploaded to the network storage, makes the Detection Information of each user can have complete preservation and analysis, and can make that the remote analysis result of data can be instant feed back to user by detector; It is convenient that fingerprint authentication makes the account of user set up, and do not repeat, and contributes to for each user sets up more complete accurate detection account, and by the impact of time, place and detecting instrument.
To sum up, the invention provides and a kind ofly tachysynthesis is quantitatively detected the solution combined with network digital health system.When user uses fluorescence immunoassay instrument by fingerprint recognition user identity, calling and obtaining user account, simultaneously can in good time distally server transmit and detect data, far-end server automatically by data-storing in the user account of correspondence.Preferred further, far-end server to detection data analysis, and can provide auxiliary diagnosis and treatment suggestion.Immunoassay technology and Internet technology combine by the present invention, the virtual world of internet and entity technology are combined, and will break the tradition of seeing a doctor and must go to hospital, are sitting in family and also can do inspection and look for well-known doctor's diagnosis and treatment.
The foregoing is only preferred embodiment of the present invention, not in order to limit the present invention, all any amendments done within the spirit and principles in the present invention, equivalent replacement and improvement etc., all should be included within protection scope of the present invention.
Claims (10)
1. the quantitative detection management method of network intelligence fluorescence immunoassay, it is characterized in that, described method comprises:
Obtain user fingerprints data;
When receiving domestic consumer's instruction, judge whether there is described finger print data in local regular account;
If there is described finger print data, then preserve current detection result and be saved in fixing account corresponding to described finger print data, described testing result being uploaded to far-end server simultaneously;
If there is not described finger print data, then set up holding account and described finger print data and testing result are uploaded to far-end server; Upgrade user profile to make far-end server and return user ID;
When after the user ID receiving far-end server passback, if this locality exists fixing account corresponding to described user ID, then to download and the history of preserving this user detects data, otherwise upgrade described holding account for fixing account according to described user ID.
2. method as claimed in claim 1, is characterized in that, after described acquisition user fingerprints data step, also comprise the steps:
When receiving leading subscriber instruction, if there is described finger print data in local management account, then enter management mode, otherwise etc. the administrator password of user to be obtained input, if the administrator password obtained is correct, in account executive, preserves described finger print data and enter management mode.
3. method as claimed in claim 1 or 2, it is characterized in that, described method also comprises:
Preserve the diagnostic result information that far-end server passes down, when diagnostic result is for sending alarm signal time abnormal.
4. the quantitative detection management method of network intelligence fluorescence immunoassay, it is characterized in that, described method comprises:
The testing result that reception detector is uploaded and finger print data;
Judge whether to there is the user account corresponding with described finger print data;
When it is present, directly preserve testing result, and return user ID corresponding to described user account to detector;
When not existing, distributing a user ID for described finger print data and setting up user account, returning described user ID to detector simultaneously.
5. method as claimed in claim 4, it is characterized in that, described method also comprises:
The history corresponding to each user account detects data analysis, and to detector passback diagnostic result.
6. a fluorescence immunoassay instrument, is characterized in that, described detector comprises:
Fingerprint acquiring unit, for obtaining user fingerprints data;
Fingerprint judging unit, for when receiving domestic consumer's instruction, judges whether there is described finger print data in local regular account;
Data preserve uploading unit, if for there is described finger print data, then preserve current detection result and are saved in fixing account corresponding to described finger print data, described testing result being uploaded to far-end server simultaneously;
Account sets up unit, if for there is not described finger print data, then sets up holding account and described finger print data and testing result are uploaded to far-end server; Upgrade user profile to make far-end server and return user ID;
Account update process unit, for when receive far-end server passback user ID after, if this locality exists fixing account corresponding to described user ID, then to download and the history of preserving this user detects data, otherwise upgrade described holding account for fixing account according to described user ID.
7. detector as claimed in claim 6, it is characterized in that, described detector also comprises:
Management control unit, for when receiving leading subscriber instruction, if there is described finger print data in local management account, then enter management mode, otherwise etc. the administrator password of user's input to be obtained, if the administrator password obtained is correct, in account executive, preserves described finger print data and enter management mode.
8. detector as claimed in claims 6 or 7, it is characterized in that, described detector also comprises:
Result treatment unit, for preserving the diagnostic result information that far-end server passes down, when diagnostic result is for sending alarm signal time abnormal.
9. a far-end server, is characterized in that, described far-end server comprises
Data receipt unit, for receiving the testing result and finger print data that detector uploads;
, there is the user account corresponding with described finger print data for judging whether in account judging unit;
User ID back propagation unit, for directly preserving testing result when it is present, and returns user ID corresponding to described user account to detector;
Account sets up unit, for when not existing, distributing a user ID and set up user account for described finger print data, returns described user ID to detector simultaneously.
10. the quantitative detection management system of network intelligence fluorescence immunoassay, it is characterized in that, described system comprises the fluorescence immunoassay instrument as described in any one of claim 6-8, and far-end server as claimed in claim 9, and both are connected by wireless network.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410242622.5A CN105224841B (en) | 2014-06-03 | 2014-06-03 | A kind of network intelligence fluorescence immunoassay quantifies detection management method and system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410242622.5A CN105224841B (en) | 2014-06-03 | 2014-06-03 | A kind of network intelligence fluorescence immunoassay quantifies detection management method and system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105224841A true CN105224841A (en) | 2016-01-06 |
| CN105224841B CN105224841B (en) | 2018-05-25 |
Family
ID=54993806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410242622.5A Active CN105224841B (en) | 2014-06-03 | 2014-06-03 | A kind of network intelligence fluorescence immunoassay quantifies detection management method and system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105224841B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110501504A (en) * | 2018-05-16 | 2019-11-26 | 深圳市理邦精密仪器股份有限公司 | Blood content detection method and system |
| CN111710771A (en) * | 2020-05-13 | 2020-09-25 | 浙江云科智造科技有限公司 | Rubber powder ratio recommendation method for LED product |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102622522A (en) * | 2012-03-19 | 2012-08-01 | 中国科学院上海技术物理研究所 | Handheld mobile type safety telemedicine health status monitoring system |
| CN103106327A (en) * | 2011-11-15 | 2013-05-15 | 马欣 | Remote real-time family health monitoring system |
| CN103473625A (en) * | 2013-08-16 | 2013-12-25 | 上海华美络信息技术有限公司 | Chronic disease management system |
| CN103903413A (en) * | 2014-04-09 | 2014-07-02 | 时云医疗科技（上海）有限公司 | Dynamic monitoring and managing system and dynamic monitoring and managing method for heart and cerebral vessel risks |
-
2014
- 2014-06-03 CN CN201410242622.5A patent/CN105224841B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103106327A (en) * | 2011-11-15 | 2013-05-15 | 马欣 | Remote real-time family health monitoring system |
| CN102622522A (en) * | 2012-03-19 | 2012-08-01 | 中国科学院上海技术物理研究所 | Handheld mobile type safety telemedicine health status monitoring system |
| CN103473625A (en) * | 2013-08-16 | 2013-12-25 | 上海华美络信息技术有限公司 | Chronic disease management system |
| CN103903413A (en) * | 2014-04-09 | 2014-07-02 | 时云医疗科技（上海）有限公司 | Dynamic monitoring and managing system and dynamic monitoring and managing method for heart and cerebral vessel risks |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110501504A (en) * | 2018-05-16 | 2019-11-26 | 深圳市理邦精密仪器股份有限公司 | Blood content detection method and system |
| CN110501504B (en) * | 2018-05-16 | 2024-03-12 | 深圳市理邦精密仪器股份有限公司 | Blood content detection method and system |
| CN111710771A (en) * | 2020-05-13 | 2020-09-25 | 浙江云科智造科技有限公司 | Rubber powder ratio recommendation method for LED product |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105224841B (en) | 2018-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11257215B2 (en) | Systems and methods for collecting and transmitting assay results | |
| US9945837B2 (en) | Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples | |
| Vasan et al. | Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study | |
| US20130080071A1 (en) | Systems and methods for sample processing and analysis | |
| CN106404783B (en) | Test paper detecting method and device | |
| CN201247467Y (en) | Non-paper healthiness information system | |
| US20230064667A1 (en) | Method for automatically unblocking or blocking a computer-supported medical device | |
| CN107767949A (en) | A kind of primary care system | |
| CN207558437U (en) | Intelligent medical equipment, medical kit and medical system based on multiple terminals | |
| CN107292096A (en) | Clinical examination report auditing system and method based on bar code scan | |
| Latha et al. | Smart card based integrated electronic health record system for clinical practice | |
| Bernabé-Ortiz et al. | Diagnostics and monitoring tools for noncommunicable diseases: a missing component in the global response | |
| US20050060599A1 (en) | Distributed testing apparatus and host testing apparatus | |
| CN105224841A (en) | The quantitative detection management method and system of a kind of network intelligence fluorescence immunoassay | |
| WO2013043204A1 (en) | Systems and methods for collecting and transmitting assay results | |
| CN107194189A (en) | Clinical examination information processing system and method | |
| US20210161461A1 (en) | System and method for cervical cancer screening | |
| CN110251140A (en) | A kind of blood sugar detecting method and equipment | |
| CN114678093A (en) | Detection information processing method and system | |
| CN107220512A (en) | Clinical examination report preparing system and method | |
| KR200346526Y1 (en) | Monitoring system of healh status using urine analyser | |
| CN112147134A (en) | Semi-quantitative auxiliary interpretation system for in vitro diagnostic reagent | |
| CN107292370A (en) | Clinical examination information security processing system and method based on bar code | |
| CN103989456B (en) | Therapeutic medical determinator and the system of mensuration | |
| KR20180045116A (en) | Apparatus for managing diagnosis of poc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 430075 4th floor, building a87-1, accelerator phase II, biomedical park, No. 858, Gaoxin Avenue, Donghu high tech Development Zone, Wuhan, Hubei Province Patentee after: Wuhan Newcando Biotechnology Co.,Ltd. Address before: 430075 a87-1, phase II, biomedical park, Guanggu 7th Road, Donghu high tech Development Zone, Wuhan City, Hubei Province Patentee before: WUHAN NIUKANGDU BIOTECHNOLOGY Co.,Ltd. |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A network intelligent fluorescent immune quantitative detection management method and system Effective date of registration: 20210902 Granted publication date: 20180525 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: WUHAN NEWCANDO BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021420000084 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhu Hui Inventor before: Cai Lei Inventor before: Zhu Hui Inventor before: Zheng Zhongliang Inventor before: Wu Qiongshui |
|
| CB03 | Change of inventor or designer information | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230809 Granted publication date: 20180525 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: WUHAN NEWCANDO BIOTECHNOLOGY Co.,Ltd. Registration number: Y2021420000084 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |